OUR PRODUCTS





















ESOLAM
Tablet
(Enteric Coated)
Esomeprazole 20 mg.
Esomeprazole 40 mg.
Composition:
Esolam-20 Capsule: Each capsule contains enteric coated pellets of Esomeprazole Magnesium Trihydrate USP equivalent to Esomeprazole 20 mg.
Esolam-40 Capsule: Each capsule contains enteric coated pellets of Esomeprazole Magnesium Trihydrate USP equivalent to Esomeprazole 40 mg.
Pharmacology:
Esomeprazole, the S-isomer of Omeprazole, reduces gastric acid secretion through specific inhibition of the acid pump in the parietal cell, where it is concentrated and converted to the active form in the acid environment of the secretory canaliculi and inhibits the enzyme H+K+ATPase in the acid pump. The effect of the final step of the gastric acid secretion is dose-dependent and provides effective inhibition of both basal and stimulated acid secretion. Food intake has no significant influence on the effect of esomeprazole on intragastric acidity.
Indication:
Treatment of Gastroesophageal Reflux Disease (GERD)
Healing of erosive esophagitis
Maintenance of healing of erosive esophagitis
Symptomatic relief of Gastroesophageal Reflux Disease (GERD)
Risk reduction of NSAID-associated gastric ulcer
H. pylori eradication (Triple therapy).
Dosage & Administration:
Capsule: Recommended adult dosage schedule of Esomeprazole
Indication | Dose | Frequency |
|---|---|---|
Gastroesophageal Reflux Diseases (GERD) | ||
Healing of erosive esophagitis | 20 mg or 40 mg | Once daily for 4 to 8 weeks * |
Maintenance of healing of erosive esophagitis | 20 mg | Once daily ** |
Symptomatic relief of GERD | 20 mg | Once daily for 4 weeks *** |
Risk reduction of NSAID-associated gastric ulcers | 20 mg | Once daily for up to 6 months ** |
H. pylori eradication (Triple therapy) | Twice daily for 10 days | |
Esomeprazole | 20 mg | |
Amoxicillin | 1000 mg | |
Clarithromycin | 500 mg |
*The majority of patients are healed within 4 to 8 weeks. For patients who do not heal after 4 to 8 weeks, an additional 4 to 8 weeks treatment may be considered.
**Controlled studies did not extend beyond six months.
***If symptoms do not resolve completely after 4 weeks, an additional 4 weeks of treatment may be considered.
Contraindication:
Esomeprazole is contraindicated in those patients who have known hypersensitivity to any other components of the formulation.
Warning and Precautions:
Special Population:
Geriatric: No dosage adjustment is necessary.
Renal insufficiency: No dosage adjustment is necessary.
Hepatic insufficiency: No dosage adjustment is necessary in patients with mild to moderate liver impairment. For patients with severe liver impairment, a dose of 20 mg should not be exceeded.
Precautions:
Gender: No dosage adjustment is necessary.
Include the possibility of malignancy when gastric ulcer is suspected and before treatment for dyspepsia.
When using in combination with an antibiotic, refer to the prescribing information of the respective antibiotics.
Side Effect:
Side effects reported with Esomeprazole include headache, diarrhea, and abdominal pain.
Use in Pregnancy and Lactation:
US FDA Pregnancy Category: B
Teratology studies have been performed in animals and have revealed no evidence of impaired fertility or harm to the fetus due to Esomeprazole. However, there are no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed.
Use in Children & Adolescents:
Short-term treatment of GERD: 20 mg or 40 mg once daily for up to 8 weeks.
Drug Interaction:
Esomeprazole appears to be a selective inhibitor of the cytochrome P450 monooxygenase system. There may be an effect on hepatic clearance, but there have been no reports to date of clinically relevant interactions. There is some uncertainty over the effect of Esomeprazole on the oral combined contraceptive pill. Further assessment is currently underway. Physiological changes similar to those found with Omeprazole are likely to take place because of the reduction in gastric acid, which is likely to influence the bacterial colonization of the stomach and duodenum and also vitamin B12 absorption.
Overdose:
There is no experience to date with deliberate overdose. Data are limited, but single doses of 80 mg Esomeprazole were uneventful. Esomeprazole is extensively plasma protein bound and is therefore not readily dialyzable. As in any case of overdose, treatment should be symptomatic and general supportive measures should be utilized.
Storage:
Store in a cool (below 30°C) and dry place, protect from light. Keep all medicines out of the reach of children.
Packing:
Esolam-20 Capsule: Each box contains 10 × 10 capsules in Alu-Alu blister pack.
Esolam-40 Capsule: Each box contains 6 × 10 capsules in Alu-Alu blister pack.